Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma